摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-Aethyl-N'-sec-butyl-harnstoff | 38014-59-4

中文名称
——
中文别名
——
英文名称
N-Aethyl-N'-sec-butyl-harnstoff
英文别名
N-Ethyl-N'-s-butylharnstoff;N-ethyl-N'-sec-butyl-urea;1-Butan-2-yl-3-ethylurea
<i>N</i>-Aethyl-<i>N</i>'-<i>sec</i>-butyl-harnstoff化学式
CAS
38014-59-4
化学式
C7H16N2O
mdl
MFCD11701474
分子量
144.217
InChiKey
ALBAPVBGZOGMPY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    41.1
  • 氢给体数:
    2
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
    申请人:Li Hui
    公开号:US20120010406A1
    公开(公告)日:2012-01-12
    Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
    本发明涉及式I的化合物,包含它们的组合物以及使用这些化合物和组合物治疗疾病的方法。其中,调节JAK通路或抑制JAK激酶,特别是JAK 2和JAK3,在治疗中具有治疗作用。
  • METHOD FOR PRODUCING FLUORINE-CONTAINING ACYLACETIC ACID DERIVATIVE, METHOD FOR PRODUCING FLUORINE-CONTAINING PYRAZOLECARBOXYLIC ACID ESTER DERIVATIVE, AND METHOD FOR PRODUCING FLUORINE-CONTAINING PYRAZOLECARBOXYLIC ACID DERIVATIVE
    申请人:Mitsui Chemicals Agro, Inc.
    公开号:EP2263999A1
    公开(公告)日:2010-12-22
    A halogenating agent is added to a mixture including a base, a fluoroalkylcarboxylic acid derivative and an acrylate derivative to produce a fluoroaclyacetic acid derivative represented by the following Formula (3): wherein Rf represents a fluorine containing alkyl group, R1 and R2 represent a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, an arylalkyl grou p or an acyl group, or together represent an atomic group that forms a 5- or 6-memb ered ring containing a nitrogen atom to which R1 and R2 are bonded; R3 represents a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, or an arylalkyl g roup; and R4 represents an alkyl group, a cycloalkyl group, an aryl group, or an aryl alkyl group.
    在包括碱、氟烷基羧酸衍生物和丙烯酸酯衍生物的混合物中加入卤化剂,生成由下式(3)表示的氟乙酸衍生物: 其中 Rf 代表含氟烷基,R1 和 R2 代表氢原子、烷基、环烷基、芳基、芳烷基或酰基,或共同 代表一个原子团,该原子团形成一个含有氮原子的 5 或 6 嵌合环,R1 和 R2 与该环键合;R3 代表氢原子、烷基、环烷基、芳基或芳基烷基团;以及 R4 代表烷基、环烷基、芳基或芳基烷基团。
  • FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME, AND FLUORINE-CONTAINING PYRAZOLECARBOXYLIC ACID DERIVATIVE OBTAINED BY USING THE FLUORINE-CONTAINING PYRAZOLECARBONITRILE DERIVATIVE AND METHOD FOR PRODUCING THE SAME
    申请人:MITSUI CHEMICALS AGRO, INC.
    公开号:EP2128139B1
    公开(公告)日:2013-08-07
  • TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS
    申请人:Reynolds Mark
    公开号:US20120045448A1
    公开(公告)日:2012-02-23
    Compounds of the disclosure provide compositions, which are effective for prophylaxis and treatment of diseases or disorders, such as cell-proliferation, angiogenesis, or apoptosis mediated diseases. The disclosure encompasses compounds, analogs, prodrugs, metabolites, and pharmaceutically acceptable salts thereof, pharmaceutical compositions, and methods for prophylaxis and treatment of diseases and other maladies or conditions involving cancer, tumors, and like conditions. The disclosure also provides therapeutic methods including the administration of an effective amount of a compound of the disclosure.
  • US7504407B2
    申请人:——
    公开号:US7504407B2
    公开(公告)日:2009-03-17
查看更多